| ICU outcomes and survival in patients with severe COVID-19 in the largest health care system in central Florida E Oliveira, A Parikh, A Lopez-Ruiz, M Carrilo, J Goldberg, M Cearras, ... PloS one 16 (3), e0249038, 2021 | 152 | 2021 |
| Clinical Utility of Methicillin‐Resistant Staphylococcus aureus Nasal Screening for Antimicrobial Stewardship: A Review of Current Literature AL Carr, MJ Daley, K Givens Merkel, DT Rose Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 38 (12 …, 2018 | 57 | 2018 |
| Cefiderocol for the Treatment of Adult and Pediatric Patients With Cystic Fibrosis and Achromobacter xylosoxidans Infections NC Warner, LA Bartelt, AM Lachiewicz, KM Tompkins, MB Miller, K Alby, ... Clinical Infectious Diseases 73 (7), e1754-e1757, 2021 | 33 | 2021 |
| 1607. Dual therapy with aztreonam & ceftazidime/avibactam against multi-drug resistant Stenotrophomonas maltophilia on tricuspid valve endocarditis J Alexander, A Carr, SB Minor, D Navas Open Forum Infectious Diseases 7 (Suppl 1), S798, 2020 | 4 | 2020 |
| Pharmacist-Driven Methicillin-Resistant S. aureus Polymerase Chain Reaction Testing for Pneumonia V Marinucci, PR Louzon, AL Carr, J Hayes, A Lopez-Ruiz, J Sniffen Annals of Pharmacotherapy 57 (5), 560-569, 2023 | 3 | 2023 |
| Evaluating predictors of invasive candidiasis in patients with and without candidemia on micafungin A Carr, P Colley, M Berhe, HL Nguyen Baylor University Medical Center Proceedings 31 (1), 30-34, 2018 | 3 | 2018 |
| 666. Outcomes Using Cefiderocol for the Treatment of Acinetobacter baumannii Infections from the PROVE (Real-World Evidence) Study S Marcella, E Kobic, AL Carr, B Georgiades, C Margiotta Open Forum Infectious Diseases 9 (Supplement_2), ofac492. 718, 2022 | 2 | 2022 |
| Renin angiotensin aldosterone system antagonism in 2019 novel coronavirus acute lung injury D Ventura, AL Carr, RD Davis, S Silvestry, L Bogar, N Raval, C Gries, ... Open Forum Infectious Diseases 8 (10), ofab170, 2021 | 2 | 2021 |
| 1615. Isolation of Lytic Bacteriophages with Broad Host Range Activity Against Pseudomonas aeruginosa Strains Isolated from Respiratory Samples from Cystic Fibrosis Patients … J Alexander, D Navas, M Flowers, A Charles, A Carr Open Forum Infectious Diseases 7 (Suppl 1), S801, 2020 | 2 | 2020 |
| 2275. Novel therapeutic options for the treatment of multi-drug-resistant Achromobacter respiratory infections T Canonica, S Thompson, A Carr, J Alexander, SB Minor Open Forum Infectious Diseases 6 (Suppl 2), S779, 2019 | 2 | 2019 |
| Risk factors for Candidemia as Compared with patients with negative blood cultures placed on empiric micafungin A Carr, M Berhe Open Forum Infectious Diseases 4 (Suppl 1), S79, 2017 | 2 | 2017 |
| 667. Real-world Experience of Cefiderocol with Pseudomonas aeruginosa in the PROVE (Retrospective Cefiderocol Chart Review) Study S Marcella, AL Carr, E Kobic, S Nguyen, A Zhou Open Forum Infectious Diseases 9 (Supplement_2), ofac492. 719, 2022 | 1 | 2022 |
| Epidemiology and treatment of invasive Bartonella spp. infections in the United States M Pizzuti, P Bailey, C Derrick, B Albrecht, AL Carr, EW Covington, ... Infection, 1-8, 2024 | | 2024 |
| A Baker's Dozen of Top Antimicrobial Stewardship Intervention Publications in 2022 RK Barfield, ML Brown, B Albrecht, KE Barber, J Bouchard, AL Carr, ... Open Forum Infectious Diseases, ofad687, 2024 | | 2024 |
| Analytical and Clinical Validation of Direct Detection of Antimicrobial Resistance Markers by Plasma Microbial Cell-free DNA Sequencing FC Christians, J Akhund-Zade, KJ Jarman, S Venkatasubrahmanyam, ... medRxiv, 2024.03. 14.24303933, 2024 | | 2024 |
| 528: A PHARMACIST-DRIVEN MRSA PCR ALGORITHM IN CRITICALLY ILL VS NON-CRITICALLY ILL PNEUMONIA PATIENTS P Louzon, B North, V Marinucci, A Carr Critical Care Medicine 52 (1), S237, 2024 | | 2024 |
| Trimethoprim/Sulfamethoxazole vs Minocycline for the Treatment of Nonurinary Monomicrobial Stenotrophomonas maltophilia Infections in Hospitalized Patients EC Hevia, L Wooten, AL Carr Annals of Pharmacotherapy, 10600280231201850, 2023 | | 2023 |
| 181. Impact of Rapid Diagnostic Technology on Patients with Candidemia P Funderburk, AL Carr, JE Hayes Open Forum Infectious Diseases 9 (Supplement_2), ofac492. 259, 2022 | | 2022 |
| 919. Let’s GO PO: Impact of Monthly Feedback on a Longitudinal Intravenous to Oral Antimicrobial Conversion Initiative JE Hayes, AL Carr Open Forum Infectious Diseases 9 (Supplement_2), ofac492. 764, 2022 | | 2022 |
| 925. Remdesperate for Stewardship: Impact of a Remdesivir Stewardship Strategy on the Care of Patients with COVID-19 Admitted to a Community Teaching Hospital J Hayes, A Ghonim, L Wooten, J Sippel-Tompkins, V Herrera, AL Carr Open Forum Infectious Diseases 9 (Supplement_2), ofac492. 770, 2022 | | 2022 |
Arnaldo Lopez-Ruiz, MDFlorida Hospital - AdventHealth OrlandoVerified email at adventhealth.com
